Detalhe da pesquisa
1.
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
Eur Heart J
; 44(5): 396-407, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478225
2.
Comparison of the antiplatelet effect of clopidogrel hydrogenosulfate and clopidogrel besylate in patients with stable coronary artery disease.
J Thromb Thrombolysis
; 40(3): 288-93, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25662861
3.
Long-term clinical outcomes in implantable cardioverter defibrillator recipients on the island of Crete.
Hellenic J Cardiol
; 2016 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27639320
4.
Early cardiac gene transcript levels in peripheral blood mononuclear cells reflect severity in stable coronary artery disease.
Hellenic J Cardiol
; 55(2): 119-25, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24681789
5.
Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment.
J Am Coll Cardiol
; 55(24): 2753-9, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20538169
6.
Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic Peptide prohormone levels in patients with persistent atrial fibrillation.
Am J Cardiol
; 105(1): 90-4, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20102897